Literature DB >> 22213000

Cognitive dysfunction in cirrhosis is associated with falls: a prospective study.

Germán Soriano1, Eva Román, Joan Córdoba, Maria Torrens, Maria Poca, Xavier Torras, Càndid Villanueva, Ignasi J Gich, Víctor Vargas, Carlos Guarner.   

Abstract

UNLABELLED: Falls are frequent among patients with debilitating disorders and can have a serious effect on health status. Mild cognitive disturbances associated with cirrhosis may increase the risk for falls. Identifying subjects at risk may allow the implementation of preventive measures. Our aim was to assess the predictive value of the Psychometric Hepatic Encephalopathy Score (PHES) in identifying patients likely to sustain falls. One hundred and twenty-two outpatients with cirrhosis were assessed using the PHES and were followed at specified intervals. One third of them exhibited cognitive dysfunction (CD) according to the PHES (<-4). Seventeen of the forty-two patients (40.4%) with CD had at least one fall during follow-up. In comparison, only 5 of 80 (6.2%) without CD had falls (P < 0.001). Fractures occurred in 4 patients (9.5%) with CD, but in no patients without CD (P = 0.01). Patients with CD needed more healthcare (23.8% versus 2.5%; P < 0.001), more emergency room care (14.2% versus 2.5%; P = 0.02), and more hospitalization (9.5% versus 0%; P = 0.01) as a result of falls than patients without CD. Patients taking psychoactive treatment (n = 21) had a higher frequency of falls, and this was related to an abnormal PHES. In patients without psychoactive treatment (n = 101), the incidence of falls was 32.4% in patients with CD versus 7.5% in those without CD (P = 0.003). In the multivariate analysis, CD was the only independent predictive factor of falls (odds ratio, 10.2; 95% confidence interval, 3.4-30.4; P < 0.001). The 1-year probability of falling was 52.3% in patients with CD and 6.5% in those without (P < 0.001).
CONCLUSION: An abnormal PHES identifies patients with cirrhosis who are at risk for falls. This psychometric test may be useful to promote awareness of falls and identify patients who may benefit from preventive strategies.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22213000     DOI: 10.1002/hep.25554

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

1.  Liver: risk of falls in cirrhosis predicted by psychometric testing.

Authors:  Roger F Butterworth
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

Review 2.  Advances in psychometric tests for screening minimal hepatic encephalopathy: From paper-and-pencil to computer-aided assessment.

Authors:  Ming Luo; Ping Ma; Lei Li; Wu-Kui Cao
Journal:  Turk J Gastroenterol       Date:  2019-05       Impact factor: 1.852

Review 3.  Diagnosis of minimal hepatic encephalopathy.

Authors:  Karin Weissenborn
Journal:  J Clin Exp Hepatol       Date:  2014-07-31

Review 4.  Minimal hepatic encephalopathy impairs quality of life.

Authors:  Swastik Agrawal; Sridharan Umapathy; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-04

Review 5.  Contemporary Epidemiology of Cirrhosis.

Authors:  Jad A Baki; Elliot B Tapper
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

6.  An association between dietary habits and traffic accidents in patients with chronic liver disease: A data-mining analysis.

Authors:  Takumi Kawaguchi; Takuro Suetsugu; Shyou Ogata; Minami Imanaga; Kumiko Ishii; Nao Esaki; Masako Sugimoto; Jyuri Otsuyama; Ayu Nagamatsu; Eitaro Taniguchi; Minoru Itou; Tetsuharu Oriishi; Shoko Iwasaki; Hiroko Miura; Takuji Torimura
Journal:  Biomed Rep       Date:  2016-03-23

7.  Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Authors:  Vishwadeep Ahluwalia; Douglas M Heuman; George Feldman; James B Wade; Leroy R Thacker; Edith Gavis; HoChong Gilles; Ariel Unser; Melanie B White; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2014-08-08       Impact factor: 25.083

8.  The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.

Authors:  Jasmohan S Bajaj; Leroy R Thacker; Douglas M Heuman; Michael Fuchs; Richard K Sterling; Arun J Sanyal; Puneet Puri; Mohammad S Siddiqui; Richard T Stravitz; Iliana Bouneva; Velimir Luketic; Nicole Noble; Melanie B White; Pamela Monteith; Ariel Unser; James B Wade
Journal:  Hepatology       Date:  2013-05-23       Impact factor: 17.425

Review 9.  Encephalopathy and liver transplantation.

Authors:  Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2012-11-16       Impact factor: 3.584

10.  Diagnosis of covert hepatic encephalopathy without specialized tests.

Authors:  Eiman Nabi; Leroy R Thacker; James B Wade; Richard K Sterling; R Todd Stravitz; Michael Fuchs; Douglas M Heuman; Iliana Bouneva; Arun J Sanyal; Mohammad S Siddiqui; Velimir Luketic; Melanie B White; Pamela Monteith; Nicole A Noble; Ariel Unser; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-19       Impact factor: 11.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.